Annual Total Long Term Liabilities
$186.73 M
+$57.77 M+44.79%
December 31, 2023
Summary
- As of February 12, 2025, KYTX annual total long term liabilities is $186.73 million, with the most recent change of +$57.77 million (+44.79%) on December 31, 2023.
- During the last 3 years, KYTX annual total long term liabilities has risen by +$70.92 million (+61.24%).
- KYTX annual total long term liabilities is now at all-time high.
Performance
KYTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$5.50 M
-$628.00 K-10.25%
September 30, 2024
Summary
- As of February 12, 2025, KYTX quarterly total long term liabilities is $5.50 million, with the most recent change of -$628.00 thousand (-10.25%) on September 30, 2024.
- Over the past year, KYTX quarterly long term liabilities has dropped by -$181.23 million (-97.05%).
- KYTX quarterly long term liabilities is now -97.06% below its all-time high of $187.42 million, reached on September 1, 2023.
Performance
KYTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
KYTX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.8% | -97.0% |
| 3 y3 years | +61.2% | -97.0% |
| 5 y5 years | +61.2% | -97.0% |
KYTX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.2% | -97.1% | at low |
| 5 y | 5-year | at high | +61.2% | -97.1% | at low |
| alltime | all time | at high | +61.2% | -97.1% | at low |
Kyverna Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.50 M(-10.2%) |
| Jun 2024 | - | $6.13 M(-14.0%) |
| Mar 2024 | - | $7.13 M(-96.2%) |
| Dec 2023 | $186.73 M | $186.73 M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $187.42 M(+45.3%) |
| Dec 2022 | $128.97 M(+11.4%) | - |
| Dec 2022 | - | $128.97 M |
| Dec 2021 | $115.81 M | - |
FAQ
- What is Kyverna Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual total long term liabilities year-on-year change?
- What is Kyverna Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly long term liabilities year-on-year change?
What is Kyverna Therapeutics annual total long term liabilities?
The current annual total long term liabilities of KYTX is $186.73 M
What is the all time high annual total long term liabilities for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual total long term liabilities is $186.73 M
What is Kyverna Therapeutics annual total long term liabilities year-on-year change?
Over the past year, KYTX annual total long term liabilities has changed by +$57.77 M (+44.79%)
What is Kyverna Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of KYTX is $5.50 M
What is the all time high quarterly long term liabilities for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly total long term liabilities is $187.42 M
What is Kyverna Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, KYTX quarterly total long term liabilities has changed by -$181.23 M (-97.05%)